Perry A. Genova
Keine laufenden Positionen mehr
Profil
Perry A.
Genova served as President, Chief Executive Officer & Director at Oncoscope, Inc. He was also Vice President-Biomedical Engineering at KOS Pharmaceuticals, Inc. from 1996 to 2006.
In 2017, he became Senior Vice President-Research & Development at Titan Medical, Inc. He also served as Global Vice President at GlaxoSmithKline Sante Grand Public SAS.
Dr. Genova holds a graduate and doctorate degree from The University of North Carolina at Charlotte.
Ehemalige bekannte Positionen von Perry A. Genova
| Unternehmen | Position | Ende |
|---|---|---|
| TITAN MEDICAL INC. | Chief Tech/Sci/R&D Officer | 01.06.2022 |
KOS Pharmaceuticals, Inc.
 KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Corporate Officer/Principal | - |
GlaxoSmithKline Sante Grand Public SAS
 GlaxoSmithKline Sante Grand Public SAS Medical DistributorsDistribution Services Glaxosmithkline Sante Grand Public wholesales pharmaceutical products. The company is headquartered in Rueil-malmaison, France. | Corporate Officer/Principal | - |
Oncoscope, Inc.
 Oncoscope, Inc. Medical/Nursing ServicesHealth Services Oncoscope, Inc. develops optical imaging systems for the early detection of cancers. Its product is Barrett's Esophagus. The firm operates as a medical device company that develops proprietary optical imaging systems for epithelial tissues in the oral cavity, esophagus, stomach, colon, lung, cervix and bladder. Its systems provide in vivo measurements of the diameter and density of cell nuclei. The company was founded by William J. Brown and Adam Wax in June 2006 and is headquartered in Durham, NC. | Chief Executive Officer | - |
Ausbildung von Perry A. Genova
| The University of North Carolina at Charlotte | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TITAN MEDICAL INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
KOS Pharmaceuticals, Inc.
KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Health Technology |
Oncoscope, Inc.
Oncoscope, Inc. Medical/Nursing ServicesHealth Services Oncoscope, Inc. develops optical imaging systems for the early detection of cancers. Its product is Barrett's Esophagus. The firm operates as a medical device company that develops proprietary optical imaging systems for epithelial tissues in the oral cavity, esophagus, stomach, colon, lung, cervix and bladder. Its systems provide in vivo measurements of the diameter and density of cell nuclei. The company was founded by William J. Brown and Adam Wax in June 2006 and is headquartered in Durham, NC. | Health Services |
GlaxoSmithKline Sante Grand Public SAS
GlaxoSmithKline Sante Grand Public SAS Medical DistributorsDistribution Services Glaxosmithkline Sante Grand Public wholesales pharmaceutical products. The company is headquartered in Rueil-malmaison, France. | Distribution Services |
